Showing posts with label OCRF. Show all posts
Showing posts with label OCRF. Show all posts

Sunday, February 3, 2013

Listen for the Whisper - Survivors Teaching Students

We hear the stories much too often - repeated visits to health care professionals before Ovarian Cancer diagnosis. Diagnosis at later stages, when the key to survival is early detection.

Ovarian Cancer National Alliance has an instituted an education program for health professionals - Survivors Teaching Students: Saving Women's Lives® - to bring ovarian cancer survivors into the classrooms and tell their stories of late stage diagnosis. Students - physicians, nurses and nurse practitioners as well as physicians assistants -  will hear the personal experiences of women and their path to diagnosis and survival. Understanding the disease beyond the statistics; by looking at the faces of the women who struggled to have their symptoms understood, will lead to earlier diagnosis,  more compassionate practitioners and better patient care.

This program brings to light the need for increased sensitivity towards symptom awareness in the medical profession. Watch the video and get more information at ovariancancer.org.

Sunday, April 22, 2012

Cancer Warrior - Dr. Ernst Lengyl

The goal for more survivors, targeted therapy treatments and teamwork in research is the goal of the Ovarian Cancer Research Fund. At the 2011 Survive and Thrive course at the Feinburg School of Medicine, one of the speakers was Dr. Ernst Lengyl of the University of Chicago. Dr. Lengyl, a gynecological oncologist and cell biologist, is a 2004 and 2005 Liz Tiberis award winner and a 2012 OCRF Program Project Development Grant Recipient. Dr Lengyl's team will be focusing on microRNA's in normal healthy cells being re-programmed by tumor cells.

I think I can speak for several in the lecture hall that day at Feinburg when I say that we were not all able to grasp the high level of science that Dr. Lengyl presented to us. Still knowing that right here at The Lengyl lab at U of C, Dr. Lengyl and his team have a goal - to improve survival and to meet the challenges that make ovarian cancer the most deadly gynecological cancer, and to beat it.

I feel privileged to have heard Dr. Lengyl and hope that very soon Dr. Lengyl's name will be linked with the CURE for ovarian cancer. There are times when ribbons just don't seem like enough. When you want to do more, consider donating to OCRF.

Saturday, March 10, 2012

March - Celebrating Women's History Month

Thanks to the Ovarian Cancer Research Fund for spreading the news that March is Women's History Month. It is a good time to share the story of a pioneering woman of science - Rosalind Franklin - a brilliant, young British biophysicist whose x-ray diffraction photos and research uncovered the structure of DNA -  double-helix shape. Franklin did not share in the Noble Prize awarded to those who used her research, as she died of ovarian cancer in 1958. This most important advancement in modern biology was not the only contribution as Dr. Franklin also spearhead pioneering work on the tobacco mosaic and polio viruses. Diagnosed with ovarian cancer at 35, Dr. Franklin was a tireless champion continuing to work through the next two years until her death, through three operations and experimental chemotherapy. Although her work as an x-ray crystallographer exposed her to continual doses of radiation, it is possible that Dr. Franklin's had a genetic pre-disposition to ovarian cancer commonly found among those of Ashkenazi Jew heritage. Celebrate another Courageous Fighter.